U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further investments planned, CEO Robert Bradway said at the inauguration of the site on Monday.

Amgen (NASDAQ: AMGN) is investing $200 million in its new technology and innovation center in Hyderabad, India, to enhance AI and data-driven drug development. CEO Robert Bradway, speaking at the sites inauguration,

Amgen, a leading American biopharmaceutical company, is set to invest $200 million in a new Technology and Innovation Centre. The inauguration took place with notable attendees, including India's Chief Minister Revanth Reddy.

Amgen India opens in Hyderabad, investing $200 million in technology and innovation to advance global healthcare.

American multinational biopharmaceutical company, Amgen will be investing USD 200 million (about Rs 1600 crore) in its new Technology and Innovation centre this year here. Chief Minister A Revanth Reddy and Industries Minister D Sridhar Babu on Monday inaugurated the Amgen Innovation Site at the Amgen office premises near Hitech City,

US-based biopharma giant on Monday opened its new technology and innovation centre in Hyderabad with its CEO Robert Bradway announcing a $2.

Global biotech leader Amgen opened its $200 million technology and innovation centre in Hyderabad, a facility that will help the U.S. firm ramp up digital capabilities, open more opportunities for the talent pool of the region and build on the city’s position as an emerging hub for global capability centres (GCC).

U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further investments planned, Chief Executive Officer Robert Bradway said at the inauguration of the site on Monday.

U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further investments planned, Chief Executive Officer Robert A. Bradway said at the inauguration of the site.